Exclusive interview lead by PharmaBoardroom

16 March 2021 Hits: 4963

Nicolas Fischer, CEO introduces Light Chain Bioscience | Novimmune SA.

GENEVA, SWITZERLAND/ SWITZERLAND BIOTECH - PHARMA BOARDROOM/ MARCH 16, 2021 /

↠Read full [ARTICLE] :

exclusive interview lead by pharmaboardroom

PharmaBoardroom Limited

International House
24 Holborn Viaduct
London, EC1A 2BN, UK

+44 20 7867 37 17
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Written by Remi Jeandenand on Tuesday, 14 January 2025. Posted in News

NI-3201 Is a Bispecific Antibody Mediating PD-L1–Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control

N
E
W
S